Building a Statistics Education Program for Preclinical Cancer Researchers
为临床前癌症研究人员建立统计教育计划
基本信息
- 批准号:10017922
- 负责人:
- 金额:$ 3.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-13 至 2020-12-31
- 项目状态:已结题
- 来源:
- 关键词:Antineoplastic AgentsBiomedical ResearchCardiovascular DiseasesClinicalCommunitiesCommunity Clinical Oncology ProgramComplexComputer softwareComputersDataData AnalysesDiseaseDropsEducationEducational CurriculumExperimental DesignsFailureFoundationsFrequenciesGenomicsGoalsHand functionsHeadHumanInstructionInvestigationKnowledgeLaboratoriesLaboratory ResearchLaboratory StudyLeadMalignant NeoplasmsMemorial Sloan-Kettering Cancer CenterMethodsModelingMolecularNaturePhase III Clinical TrialsPostdoctoral FellowProceduresPublishingR programming language ReportingResearchResearch PersonnelResourcesScienceSeveritiesSourceStatistical MethodsTestingTimeTrainingTranslatingTranslationsUnited States National Institutes of Healthanticancer activityanticancer researchbasecancer statisticscareerdesigneffective therapyexperienceexperimental studyflipped classroomimprovedlaboratory experimentlecture noteslecturespre-clinicalpre-clinical researchprogramsscaffoldstatisticssuccesstooltumor
项目摘要
ABSTRACT
In the past decade, the cancer research community has made considerable progress in characterizing the
genomic features of human tumors. Knowledge of molecular drivers of cancer has therefore increased greatly.
Although the oncology community hoped that this would lead to more effective therapies, our ability to translate
laboratory cancer research into clinical success has been remarkably low – only 5% of the agents
demonstrated to have anticancer activity in laboratory studies went on to achieve success in phase III clinical
trials. Many factors are responsible for this disturbingly high percentage of failures, including misuse or
misunderstanding of statistical design and analysis concepts, interpretation and reporting methods. Although
correctable, these issues are widely prevalent in the cancer biomedical research enterprise. Another concern is
that statistics training is not a required component of graduate programs in biomedical sciences. Recognizing
the seriousness of these issues, the National Institutes of Health has called for the full engagement of the
entire biomedical research enterprise to implement the resources needed to improve and sustain the statistical
rigor and successful translation of preclinical cancer research. To this end, we propose to develop a statistics
curriculum for early-career preclinical cancer researchers (i.e., postdoctoral researchers) conducting laboratory
research at Memorial Sloan Kettering Cancer Center as well as the broader research community. Our
proposed curriculum will be delivered over a 10-week period with one 90-minute class per week in a flipped
classroom format, where lecture notes will be disseminated one week prior to each classroom contact and
classroom time will be dedicated to hands-on activities with experimental designs, data analysis and
participatory dialogues. We will develop a plan for evaluating our proposed curriculum and make all the
resources available to the broader statistics and cancer research communities.
抽象的
在过去的十年中,癌症研究界在描述癌症特征方面取得了相当大的进展。
因此,对人类肿瘤的基因组特征的了解大大增加。
尽管肿瘤学界希望这将带来更有效的治疗方法,但我们的翻译能力
实验室癌症研究转化为临床的成功率非常低——只有 5% 的药物
在实验室研究中具有抗癌活性,并在 III 期临床中取得成功
造成这种令人不安的高失败率的因素有很多,包括误用或错误。
对统计设计和分析概念、解释和报告方法的误解。
可以纠正的是,这些问题在癌症生物医学研究企业中广泛存在。
认识到统计培训不是生物医学研究生课程的必需组成部分。
鉴于这些问题的严重性,美国国立卫生研究院呼吁各部门充分参与
整个生物医学研究企业实施改善和维持统计所需的资源
为此,我们建议制定一项统计数据。
早期职业临床前癌症研究人员(即博士后研究人员)进行实验室的课程
纪念斯隆凯特琳癌症中心以及更广泛的研究界的研究。
拟议的课程将在 10 周内提供,每周一节 90 分钟的翻转课程
课堂形式,讲稿将在每次课堂接触前一周分发,并且
课堂时间将致力于实验设计、数据分析和实践活动
我们将制定一项计划来评估我们提议的课程,并制定所有计划。
提供给更广泛的统计和癌症研究界的资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sujata Patil其他文献
Sujata Patil的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sujata Patil', 18)}}的其他基金
Building a Statistics Education Program for Preclinical Cancer Researchers
为临床前癌症研究人员建立统计教育计划
- 批准号:
10334860 - 财政年份:2021
- 资助金额:
$ 3.06万 - 项目类别:
相似国自然基金
生物医学跨本体术语相似度方法及其在B细胞非霍奇金淋巴瘤中的应用研究
- 批准号:62372276
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
面向生物医学文本的知识自动总结研究
- 批准号:72304189
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
水凝胶光纤氧气传感关键问题研究及在生物医学中的应用
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
金属配位诱导的靶向蛋白降解平台的构建及生物医学应用研究
- 批准号:22277141
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
面向生物医学领域的多模态学术图像不端检测技术研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
相似海外基金
Unraveling the role of endothelium in chemotherapy-induced cardiotoxicity
揭示内皮在化疗引起的心脏毒性中的作用
- 批准号:
10543095 - 财政年份:2022
- 资助金额:
$ 3.06万 - 项目类别:
Unraveling the role of endothelium in chemotherapy-induced cardiotoxicity
揭示内皮在化疗引起的心脏毒性中的作用
- 批准号:
10340657 - 财政年份:2022
- 资助金额:
$ 3.06万 - 项目类别:
Regeneration and remodeling of collecting lymphatic vessels post-injury
损伤后集合淋巴管的再生和重塑
- 批准号:
10534652 - 财政年份:2021
- 资助金额:
$ 3.06万 - 项目类别:
Regeneration and remodeling of collecting lymphatic vessels post-injury
损伤后集合淋巴管的再生和重塑
- 批准号:
10156902 - 财政年份:2021
- 资助金额:
$ 3.06万 - 项目类别:
Center for Biomedical Research Excellence, Epigenomics of Development and Disease
卓越生物医学研究中心,发育与疾病表观基因组学
- 批准号:
8891458 - 财政年份:2013
- 资助金额:
$ 3.06万 - 项目类别: